cd44 viobright fitc Search Results


cd44 viobright fitc  (Miltenyi Biotec)
94
Miltenyi Biotec cd44 viobright fitc
Cd44 Viobright Fitc, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd44+viobright+fitc/CD44+Antibody%2C+anti-mouse%2C+REAfinity/pm39339987-114-33-37
Average 94 stars, based on 1 article reviews
cd44 viobright fitc - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier
primary antibodies  (Miltenyi Biotec)
99
Miltenyi Biotec primary antibodies
Primary Antibodies, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd44+viobright+fitc/CD3%CE%B5+Antibody%2C+anti-mouse%2C+REAfinity/pmc08616607-321-0-4
Average 99 stars, based on 1 article reviews
primary antibodies - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier
cd49f antibody, anti-human/mouse  (Miltenyi Biotec)
94
Miltenyi Biotec cd49f antibody, anti-human/mouse
Cd49f Antibody, Anti Human/Mouse, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd44+viobright+fitc/CD49f+Antibody%2C+anti-human%2Fmouse/custom%40130-097-245%4026775583
Average 94 stars, based on 1 article reviews
cd49f antibody, anti-human/mouse - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier
cd40 antibody  (NSJ Bioreagents)
94
NSJ Bioreagents cd40 antibody
Cd40 Antibody, supplied by NSJ Bioreagents, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd44+viobright+fitc/CD40+Antibody/custom%40v8350%4035073310
Average 94 stars, based on 1 article reviews
cd40 antibody - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier
7-aad  (Becton Dickinson)
90
Becton Dickinson 7-aad
7 Aad, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd44+viobright+fitc/7+aad/10__1080_slash_2162402x__2022__2043673-45-88-91
Average 90 stars, based on 1 article reviews
7-aad - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
cd4 viobright fitc  (Miltenyi Biotec)
95
Miltenyi Biotec cd4 viobright fitc
a Immunization scheme and sample collection schedule. Mice ( n = 5) were immunized intramuscularly at day 0 (prime) and 21(boost) with 1 µg of mRNA/animal. Blood samples were obtained at week 3 (prior to boost) and 6, and specific antibody levels were determined in serum. T-cell response was evaluated in splenocytes 3 weeks post-boost. b Reciprocal endpoint titers of antigen-specific IgG antibodies in serum samples determined by ELISA using RBD recombinant protein from wild-type variant. c Neutralization titers in serum samples were determined by neutralization assay using Spike-pseudotyped lentivirus and infection in HEK293T-ACE2-TMPRSS2 cells. NT50 titers refer to the dilution of a serum sample at which 50% of the pseudovirus infection is inhibited. d IFN-γ-secreting splenocytes quantification by ELISPOT after O.N. stimulation with SARS-CoV-2 Spike peptide pool. e IFN-γ quantification in supernatants of splenocytes after overnight stimulation with SARS-CoV-2 Spike peptide pool determined by ELISA. f T-lymphocyte <t>CD4</t> and CD8 cell frequencies in spleen analyzed by flow cytometry. g Tfh and GC B cells analysis. Mice ( n = 5) were immunized intramuscularly with 5 µg of mRNA/animal. Inguinal lymph nodes were extracted on day 7. h Tfh (CD45R - , CD4 + , CD44hi, CXCR5 + , PD-1 + ) and GC B cell (CD19 + , CD95 + , GL7 + ) frequencies were determined by flow cytometry analysis. Graphs are represented as mean ± SD. * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001 as determined by two-way ANOVA ( a ) and one-way ANOVA ( c – h ) with Tukey post-test.
Cd4 Viobright Fitc, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd44+viobright+fitc/CD4+Antibody%2C+anti-mouse%2C+REAfinity/pmc12218998-431-32-34
Average 95 stars, based on 1 article reviews
cd4 viobright fitc - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier
fetal bovine serum  (Danaher Inc)
99
Danaher Inc fetal bovine serum
a Immunization scheme and sample collection schedule. Mice ( n = 5) were immunized intramuscularly at day 0 (prime) and 21(boost) with 1 µg of mRNA/animal. Blood samples were obtained at week 3 (prior to boost) and 6, and specific antibody levels were determined in serum. T-cell response was evaluated in splenocytes 3 weeks post-boost. b Reciprocal endpoint titers of antigen-specific IgG antibodies in serum samples determined by ELISA using RBD recombinant protein from wild-type variant. c Neutralization titers in serum samples were determined by neutralization assay using Spike-pseudotyped lentivirus and infection in HEK293T-ACE2-TMPRSS2 cells. NT50 titers refer to the dilution of a serum sample at which 50% of the pseudovirus infection is inhibited. d IFN-γ-secreting splenocytes quantification by ELISPOT after O.N. stimulation with SARS-CoV-2 Spike peptide pool. e IFN-γ quantification in supernatants of splenocytes after overnight stimulation with SARS-CoV-2 Spike peptide pool determined by ELISA. f T-lymphocyte <t>CD4</t> and CD8 cell frequencies in spleen analyzed by flow cytometry. g Tfh and GC B cells analysis. Mice ( n = 5) were immunized intramuscularly with 5 µg of mRNA/animal. Inguinal lymph nodes were extracted on day 7. h Tfh (CD45R - , CD4 + , CD44hi, CXCR5 + , PD-1 + ) and GC B cell (CD19 + , CD95 + , GL7 + ) frequencies were determined by flow cytometry analysis. Graphs are represented as mean ± SD. * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001 as determined by two-way ANOVA ( a ) and one-way ANOVA ( c – h ) with Tukey post-test.
Fetal Bovine Serum, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd44+viobright+fitc/FETAL+BOVINE+SERUM%2C+IRRADIATED/pmc08920250-59-19-23
Average 99 stars, based on 1 article reviews
fetal bovine serum - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier
viobright 667 isotype control  (Miltenyi Biotec)
96
Miltenyi Biotec viobright 667 isotype control
a Immunization scheme and sample collection schedule. Mice ( n = 5) were immunized intramuscularly at day 0 (prime) and 21(boost) with 1 µg of mRNA/animal. Blood samples were obtained at week 3 (prior to boost) and 6, and specific antibody levels were determined in serum. T-cell response was evaluated in splenocytes 3 weeks post-boost. b Reciprocal endpoint titers of antigen-specific IgG antibodies in serum samples determined by ELISA using RBD recombinant protein from wild-type variant. c Neutralization titers in serum samples were determined by neutralization assay using Spike-pseudotyped lentivirus and infection in HEK293T-ACE2-TMPRSS2 cells. NT50 titers refer to the dilution of a serum sample at which 50% of the pseudovirus infection is inhibited. d IFN-γ-secreting splenocytes quantification by ELISPOT after O.N. stimulation with SARS-CoV-2 Spike peptide pool. e IFN-γ quantification in supernatants of splenocytes after overnight stimulation with SARS-CoV-2 Spike peptide pool determined by ELISA. f T-lymphocyte <t>CD4</t> and CD8 cell frequencies in spleen analyzed by flow cytometry. g Tfh and GC B cells analysis. Mice ( n = 5) were immunized intramuscularly with 5 µg of mRNA/animal. Inguinal lymph nodes were extracted on day 7. h Tfh (CD45R - , CD4 + , CD44hi, CXCR5 + , PD-1 + ) and GC B cell (CD19 + , CD95 + , GL7 + ) frequencies were determined by flow cytometry analysis. Graphs are represented as mean ± SD. * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001 as determined by two-way ANOVA ( a ) and one-way ANOVA ( c – h ) with Tukey post-test.
Viobright 667 Isotype Control, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd44+viobright+fitc/REA+Control+Antibody+(S)%2C+human+IgG1%2C+REAfinity/pmc08151379-44-27-32
Average 96 stars, based on 1 article reviews
viobright 667 isotype control - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier
cd133 viobright 667  (Miltenyi Biotec)
95
Miltenyi Biotec cd133 viobright 667
a Immunization scheme and sample collection schedule. Mice ( n = 5) were immunized intramuscularly at day 0 (prime) and 21(boost) with 1 µg of mRNA/animal. Blood samples were obtained at week 3 (prior to boost) and 6, and specific antibody levels were determined in serum. T-cell response was evaluated in splenocytes 3 weeks post-boost. b Reciprocal endpoint titers of antigen-specific IgG antibodies in serum samples determined by ELISA using RBD recombinant protein from wild-type variant. c Neutralization titers in serum samples were determined by neutralization assay using Spike-pseudotyped lentivirus and infection in HEK293T-ACE2-TMPRSS2 cells. NT50 titers refer to the dilution of a serum sample at which 50% of the pseudovirus infection is inhibited. d IFN-γ-secreting splenocytes quantification by ELISPOT after O.N. stimulation with SARS-CoV-2 Spike peptide pool. e IFN-γ quantification in supernatants of splenocytes after overnight stimulation with SARS-CoV-2 Spike peptide pool determined by ELISA. f T-lymphocyte <t>CD4</t> and CD8 cell frequencies in spleen analyzed by flow cytometry. g Tfh and GC B cells analysis. Mice ( n = 5) were immunized intramuscularly with 5 µg of mRNA/animal. Inguinal lymph nodes were extracted on day 7. h Tfh (CD45R - , CD4 + , CD44hi, CXCR5 + , PD-1 + ) and GC B cell (CD19 + , CD95 + , GL7 + ) frequencies were determined by flow cytometry analysis. Graphs are represented as mean ± SD. * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001 as determined by two-way ANOVA ( a ) and one-way ANOVA ( c – h ) with Tukey post-test.
Cd133 Viobright 667, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd44+viobright+fitc/CD133%2F1+Antibody%2C+anti-human/pmc08151379-44-19-23
Average 95 stars, based on 1 article reviews
cd133 viobright 667 - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier
anti tyrosine hydroxylase pe  (Abcam)
99
Abcam anti tyrosine hydroxylase pe
a Immunization scheme and sample collection schedule. Mice ( n = 5) were immunized intramuscularly at day 0 (prime) and 21(boost) with 1 µg of mRNA/animal. Blood samples were obtained at week 3 (prior to boost) and 6, and specific antibody levels were determined in serum. T-cell response was evaluated in splenocytes 3 weeks post-boost. b Reciprocal endpoint titers of antigen-specific IgG antibodies in serum samples determined by ELISA using RBD recombinant protein from wild-type variant. c Neutralization titers in serum samples were determined by neutralization assay using Spike-pseudotyped lentivirus and infection in HEK293T-ACE2-TMPRSS2 cells. NT50 titers refer to the dilution of a serum sample at which 50% of the pseudovirus infection is inhibited. d IFN-γ-secreting splenocytes quantification by ELISPOT after O.N. stimulation with SARS-CoV-2 Spike peptide pool. e IFN-γ quantification in supernatants of splenocytes after overnight stimulation with SARS-CoV-2 Spike peptide pool determined by ELISA. f T-lymphocyte <t>CD4</t> and CD8 cell frequencies in spleen analyzed by flow cytometry. g Tfh and GC B cells analysis. Mice ( n = 5) were immunized intramuscularly with 5 µg of mRNA/animal. Inguinal lymph nodes were extracted on day 7. h Tfh (CD45R - , CD4 + , CD44hi, CXCR5 + , PD-1 + ) and GC B cell (CD19 + , CD95 + , GL7 + ) frequencies were determined by flow cytometry analysis. Graphs are represented as mean ± SD. * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001 as determined by two-way ANOVA ( a ) and one-way ANOVA ( c – h ) with Tukey post-test.
Anti Tyrosine Hydroxylase Pe, supplied by Abcam, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd44+viobright+fitc/Anti-Tyrosine+Hydroxylase+antibody/pmc08786184-196-166-170
Average 99 stars, based on 1 article reviews
anti tyrosine hydroxylase pe - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier
anti cd44  (Miltenyi Biotec)
94
Miltenyi Biotec anti cd44
a Immunization scheme and sample collection schedule. Mice ( n = 5) were immunized intramuscularly at day 0 (prime) and 21(boost) with 1 µg of mRNA/animal. Blood samples were obtained at week 3 (prior to boost) and 6, and specific antibody levels were determined in serum. T-cell response was evaluated in splenocytes 3 weeks post-boost. b Reciprocal endpoint titers of antigen-specific IgG antibodies in serum samples determined by ELISA using RBD recombinant protein from wild-type variant. c Neutralization titers in serum samples were determined by neutralization assay using Spike-pseudotyped lentivirus and infection in HEK293T-ACE2-TMPRSS2 cells. NT50 titers refer to the dilution of a serum sample at which 50% of the pseudovirus infection is inhibited. d IFN-γ-secreting splenocytes quantification by ELISPOT after O.N. stimulation with SARS-CoV-2 Spike peptide pool. e IFN-γ quantification in supernatants of splenocytes after overnight stimulation with SARS-CoV-2 Spike peptide pool determined by ELISA. f T-lymphocyte <t>CD4</t> and CD8 cell frequencies in spleen analyzed by flow cytometry. g Tfh and GC B cells analysis. Mice ( n = 5) were immunized intramuscularly with 5 µg of mRNA/animal. Inguinal lymph nodes were extracted on day 7. h Tfh (CD45R - , CD4 + , CD44hi, CXCR5 + , PD-1 + ) and GC B cell (CD19 + , CD95 + , GL7 + ) frequencies were determined by flow cytometry analysis. Graphs are represented as mean ± SD. * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001 as determined by two-way ANOVA ( a ) and one-way ANOVA ( c – h ) with Tukey post-test.
Anti Cd44, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd44+viobright+fitc/CD44+Antibody%2C+anti-mouse/pmc09043212-269-111-113
Average 94 stars, based on 1 article reviews
anti cd44 - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier
cd279 pd1 pe  (Miltenyi Biotec)
93
Miltenyi Biotec cd279 pd1 pe
a Immunization scheme and sample collection schedule. Mice ( n = 5) were immunized intramuscularly at day 0 (prime) and 21(boost) with 1 µg of mRNA/animal. Blood samples were obtained at week 3 (prior to boost) and 6, and specific antibody levels were determined in serum. T-cell response was evaluated in splenocytes 3 weeks post-boost. b Reciprocal endpoint titers of antigen-specific IgG antibodies in serum samples determined by ELISA using RBD recombinant protein from wild-type variant. c Neutralization titers in serum samples were determined by neutralization assay using Spike-pseudotyped lentivirus and infection in HEK293T-ACE2-TMPRSS2 cells. NT50 titers refer to the dilution of a serum sample at which 50% of the pseudovirus infection is inhibited. d IFN-γ-secreting splenocytes quantification by ELISPOT after O.N. stimulation with SARS-CoV-2 Spike peptide pool. e IFN-γ quantification in supernatants of splenocytes after overnight stimulation with SARS-CoV-2 Spike peptide pool determined by ELISA. f T-lymphocyte <t>CD4</t> and CD8 cell frequencies in spleen analyzed by flow cytometry. g Tfh and GC B cells analysis. Mice ( n = 5) were immunized intramuscularly with 5 µg of mRNA/animal. Inguinal lymph nodes were extracted on day 7. h Tfh (CD45R - , CD4 + , CD44hi, CXCR5 + , PD-1 + ) and GC B cell (CD19 + , CD95 + , GL7 + ) frequencies were determined by flow cytometry analysis. Graphs are represented as mean ± SD. * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001 as determined by two-way ANOVA ( a ) and one-way ANOVA ( c – h ) with Tukey post-test.
Cd279 Pd1 Pe, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd44+viobright+fitc/CD279+(PD1)+Antibody%2C+anti-mouse%2C+REAfinity/10__21203_slash_rs__3__rs___5780846_slash_v1-376-35-37
Average 93 stars, based on 1 article reviews
cd279 pd1 pe - by Bioz Stars, 2026-10
93/100 stars
  Buy from Supplier

Image Search Results


a Immunization scheme and sample collection schedule. Mice ( n = 5) were immunized intramuscularly at day 0 (prime) and 21(boost) with 1 µg of mRNA/animal. Blood samples were obtained at week 3 (prior to boost) and 6, and specific antibody levels were determined in serum. T-cell response was evaluated in splenocytes 3 weeks post-boost. b Reciprocal endpoint titers of antigen-specific IgG antibodies in serum samples determined by ELISA using RBD recombinant protein from wild-type variant. c Neutralization titers in serum samples were determined by neutralization assay using Spike-pseudotyped lentivirus and infection in HEK293T-ACE2-TMPRSS2 cells. NT50 titers refer to the dilution of a serum sample at which 50% of the pseudovirus infection is inhibited. d IFN-γ-secreting splenocytes quantification by ELISPOT after O.N. stimulation with SARS-CoV-2 Spike peptide pool. e IFN-γ quantification in supernatants of splenocytes after overnight stimulation with SARS-CoV-2 Spike peptide pool determined by ELISA. f T-lymphocyte CD4 and CD8 cell frequencies in spleen analyzed by flow cytometry. g Tfh and GC B cells analysis. Mice ( n = 5) were immunized intramuscularly with 5 µg of mRNA/animal. Inguinal lymph nodes were extracted on day 7. h Tfh (CD45R - , CD4 + , CD44hi, CXCR5 + , PD-1 + ) and GC B cell (CD19 + , CD95 + , GL7 + ) frequencies were determined by flow cytometry analysis. Graphs are represented as mean ± SD. * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001 as determined by two-way ANOVA ( a ) and one-way ANOVA ( c – h ) with Tukey post-test.

Journal: NPJ Vaccines

Article Title: Preserved efficacy of lyophilized SARS-CoV-2 mRNA vaccine incorporating novel ionizable lipids after one year at 25 °C

doi: 10.1038/s41541-025-01201-1

Figure Lengend Snippet: a Immunization scheme and sample collection schedule. Mice ( n = 5) were immunized intramuscularly at day 0 (prime) and 21(boost) with 1 µg of mRNA/animal. Blood samples were obtained at week 3 (prior to boost) and 6, and specific antibody levels were determined in serum. T-cell response was evaluated in splenocytes 3 weeks post-boost. b Reciprocal endpoint titers of antigen-specific IgG antibodies in serum samples determined by ELISA using RBD recombinant protein from wild-type variant. c Neutralization titers in serum samples were determined by neutralization assay using Spike-pseudotyped lentivirus and infection in HEK293T-ACE2-TMPRSS2 cells. NT50 titers refer to the dilution of a serum sample at which 50% of the pseudovirus infection is inhibited. d IFN-γ-secreting splenocytes quantification by ELISPOT after O.N. stimulation with SARS-CoV-2 Spike peptide pool. e IFN-γ quantification in supernatants of splenocytes after overnight stimulation with SARS-CoV-2 Spike peptide pool determined by ELISA. f T-lymphocyte CD4 and CD8 cell frequencies in spleen analyzed by flow cytometry. g Tfh and GC B cells analysis. Mice ( n = 5) were immunized intramuscularly with 5 µg of mRNA/animal. Inguinal lymph nodes were extracted on day 7. h Tfh (CD45R - , CD4 + , CD44hi, CXCR5 + , PD-1 + ) and GC B cell (CD19 + , CD95 + , GL7 + ) frequencies were determined by flow cytometry analysis. Graphs are represented as mean ± SD. * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001 as determined by two-way ANOVA ( a ) and one-way ANOVA ( c – h ) with Tukey post-test.

Article Snippet: Tfh cells were defined as CD45R - CD4 + , CD44 high , CXCR5 + , PD-1 + , and the following antibodies were used for surface staining: CD45R (B220)-APC-Vio770 (Miltenyi, 130-110-849), CD4-VioBright FITC (Miltenyi, 130-118-692), CD44-PerCP-Vio700 (Miltenyi, 130-128-625), CD185 (CXCR5)-APC (Miltenyi, 130-119-129), and CD279 (PD1)-PE (Miltenyi, 130-111-953).

Techniques: Enzyme-linked Immunosorbent Assay, Recombinant, Variant Assay, Neutralization, Infection, Enzyme-linked Immunospot, Flow Cytometry